Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
2022-06-21–2022-06-23
Equibles does not estimate personal net worth.
Joseph C. Papa was last confirmed as CEO at Bausch Health Companies Inc. (BHC) in a filing dated May 2, 2022. Earlier roles on record: Board Member at Bausch Health Companies Inc. (BHC) until June 23, 2022. Bausch & Lomb Corp reported in an 8-K filed July 20, 2022 that Joseph C. Papa resigned as Chair of the Board of Directors, effective July 20, 2022. The same filing states: “Mr. Papa’s departure is not the result of any disagreement with the Company.” Bausch Health Companies Inc. reported in an 8-K filed June 24, 2022 that Joseph C. Papa resigned as Board of Directors, effective June 23, 2022. The same filing states: “Mr. Papa’s decision to resign from the Board was not due to any dispute or disagreement with the Company, its management or the Board on any matter relating to the Company’s operations, policies or practices.” Bausch Health Companies Inc. reported in an 8-K filed June 24, 2022 that Joseph C. Papa was appointed Director, effective June 21, 2022. The proxy statement of Bausch Health Companies Inc. reports total compensation of $22,889,137 for Joseph C. Papa in fiscal 2021, including a base salary of $1,600,000. Disclosed compensation is on record for 5 fiscal years.
“Joseph C. Papa has stepped down as chair of the Board of Directors of the Company (the "Board").”
“Mr. Papa’s departure is not the result of any disagreement with the Company.”
“On June 23, 2022, Bausch Health Companies Inc. (“Bausch Health” or the “Company”) announced that Joseph C. Papa resigned from the Company’s Board of Directors (the “Board”), effective immediately.”
“Mr. Papa’s decision to resign from the Board was not due to any dispute or disagreement with the Company, its management or the Board on any matter relating to the Company’s operations, policies or practices.”
2022-06-21–2022-06-23
Start not stated–2022-05-02
Last confirmed by a filing; no departure on record
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
2022-06-21–2022-06-23
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Bausch Health Companies Inc. (BHC) | Former Chief Executive Officer | $1,600,000 | $22,889,137 |
| 2020 | Bausch Health Companies Inc. (BHC) | Former Chief Executive Officer | $1,526,539 | $14,119,361 |
| 2019 | Bausch Health Companies Inc. (BHC) | Chief Executive Officer | $1,500,000 | $17,141,646 |
| 2018 | Bausch Health Companies Inc. (BHC) | Chief Executive Officer | $1,500,000 | $14,741,050 |
| 2017 | Bausch Health Companies Inc. (BHC) | Chief Executive Officer | $1,500,000 | $4,895,108 |
“Mr. Papa’s departure is not the result of any disagreement with the Company.”
Bausch & Lomb Corp (BLCO)“Mr. Papa’s decision to resign from the Board was not due to any dispute or disagreement with the Company, its management or the Board on any matter relating to the Company’s operations, policies or practices.”
Bausch Health Companies Inc. (BHC)